Position in INCY
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$4,047
-$298 QoQ
Shares Held
43
-2.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026IMA Advisory Services, Inc. holds $5,734,538 across 18 Biotechnology names. INCY ranks #3 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
94,710 | $4,062,111 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,132 | $1,647,268 | |
| 3 | INCY |
Incyte Corp
This page
|
43 | $4,047 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
52 | $2,937 | |
| 5 | KRYS |
Krystal Biotech, Inc.
|
10 | $2,583 | |
| 6 | MRNA |
Moderna, Inc.
|
45 | $2,286 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
28 | $2,102 | |
| 8 | INSM |
INSMED Inc
|
12 | $1,962 |
All Filings in INCY
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,047 | 43 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $4,345 | 44 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $254 | 3 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $204 | 3 | Shares | Sole | 2025-08-08 | |
| No filing history on record for this holder in this stock. | ||||||